Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EVOLVE II QCA: A Prospective, Multicenter Trial to Assess the SYNERGY Everolimus-Eluting Platinum Chromium Coronary Stent System (SYNERGY Stent System) for the Treatment of Atherosclerotic Lesion(s)

NCT01787799 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT01787799
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01787799 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EVOLVE II QCA: A Prospective, Multicenter Trial to Assess the SYNERGY Everolimus-Eluting Platinum Chromium Coronary Stent System (SYNERGY Stent System) for the Treatment of Atherosclerotic Lesion(s)
Lead sponsor
Boston Scientific Corporation
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2013
Completion date
October 31, 2014
Enrollment
100 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerotic lesion(s)